Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

In a new study, researchers assessed the impact of pre-existing immunity against SARS-CoV-2 acquired by previous infections (PI) or COVID-19 vaccination on the transmission of SARS-CoV-2 variants of concern such as Delta and Omicron.

Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities

STAT2 signaling restricts viral dissemination but drives severe

SARS-CoV-2 Omicron variant: recent progress and future

Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection

Frontiers Immune Evasive Effects of SARS-CoV-2 Variants to COVID

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies

A highly efficacious live attenuated mumps virus–based SARS-CoV-2

Cross-variant protection against SARS-CoV-2 infection in hamsters

Predicting Mutational Effects on Receptor Binding of the Spike

SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease